ARRAY MARKET ANALYSIS
Array Market (Life Science and Biotechnology Instruments), By Type (DNA Array, Protein Array, Tissue Array, Cell Array), By End User (Biopharmaceutical and Pharmaceutical, Diagnostic Laboratories, Research Laboratories, Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to quantify expression levels of numbers of genes simultaneously or to genotype multiple regions of a genome. The approach finds application in drug R&D, clinical diagnosis, agriculture, environment control, and other sectors.
Statistics:
The global array market (life science and biotechnology instruments) is estimated to account for US$ 4,899.9 Mn in terms of value in 2020 and is expected to reach US$ 12,892.5 Mn by the end of 2027.
Global Array Market (Life Science and Biotechnology Instruments): Drivers
High prevalence of cancer is expected to propel growth of the global array market (life science and biotechnology instruments) over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Moreover, increasing adoption of genetic testing is also expected to propel growth of the global array market (life science and biotechnology instruments) over the forecast period. For instance, in April 2020, Axovant Gene Therapies collaborated with Invitae Corporation, a provider of advanced medical genetics, to offer free genetic testing in the U.S. and Canada for pediatric lysosomal storage disease.
Statistics:
DNA Array held dominant position in the global array market (life science and biotechnology instruments) in 2019, accounting for 50.3% share in terms of value, followed by Protein array and tissue array, respectively.
Figure 1. Global Array Market Share (%), by Value, by Type, 2019
Global Array Market (Life Science and Biotechnology Instruments): Restraints
Lack of technically trained resources, especially in emerging economies, is expected to hinder growth of the global array market (life science and biotechnology instruments). Technologically versed and skilled resources are a prerequisite for using DNA/gene microarrays and sequencers. Shortage of such trained personnel is expected to limit market growth.
Moreover, availability of alternative methods such as high throughput screening, genomics, bio-analytical instruments, pharmacogenomics, bioinformatics, proteomics, RNAi, nanotechnology, combinatorial chemistry is also expected to limit growth of the global array market (life science and biotechnology instruments).
Global Array Market (Life Science and Biotechnology Instruments): Opportunities
R&D in cancer is expected to offer lucrative growth opportunities for players in the global array market (life science and biotechnology instruments). For instance, in April 2020, researchers from National Defense Medical Center, Taiwan, reported use of DNA microarray gene expression profiles in a research to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages.
Moreover, significant development in personalized medicines is also expected to fuel growth of the global global array market (life science and biotechnology instruments) over the forecast period. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.
Statistics:
The global array market (life science and biotechnology instruments) was valued at US$ 4,276.1 Mn in 2019 and is forecast to reach a value of US$ 12,892.5 Mn by 2027 at a CAGR of 14.8% between 2020 and 2027.
Figure 2. Global Array Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027
Market Trends/Key Takeaways
Major players in the global array market (life science and biotechnology instruments) are focused on adopting M&A strategies to enhance their market share. For instance, in December 2019, Oncology Pharma, Inc. signed a Letter of Intent to acquire at least a 50% stake in Diagnomics, Inc., a private CLIA certified & CAP accredited private molecular Genomics lab and provider of DNA microarrays, Next Generation Sequencing, and real-time PCR solutions
R&D in arrays is expected to propel growth of the global array market (life science and biotechnology instruments) over the forecast period. For instance, in April 2020, researchers from National Defense Medical Center, Taiwan, reported use of DNA microarray gene expression profiles in a research to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages.
Global Array Market (Life Science and Biotechnology Instruments): Competitive Landscape
Major players operating in the global array market (life science and biotechnology instruments) include, Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.
Global Array Market (Life Science and Biotechnology Instruments): Key Developments
Major players in the global array market (life science and biotechnology instruments) are focused on launching new products to expand their product portfolio. For instance, in December 2019, PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology
Similarly, in February 2018, Thermo Fisher Scientific launched the Applied Biosystems Axiom Microbiome Array for simultaneous detection of archaea, bacteria, fungi, protozoa and viruses in human and non-human samples.
Request sample report here: https://www.coherentmarketinsights.com/insight/request-sample/4221
Download PDF brochure here: https://www.coherentmarketinsights.com/insight/request-pdf/4221
About Us:
Coherent Market Insights is a globa market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
What we provide:
· Customized market research service
· Industry analysis services
· Business consulting services
· Market intelligence services
· Long term engagement model
· Country specific analysis
Contact Us:
Mr. shah
Coherent Market Insights Pvt. Ltd.